CanaDan Bio ApS: Financial statements 2025
CVR: 40896813
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
CanaDan Bio ApS (CVR 40896813) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -1,395 and a net result of DKK 4,372 compared with DKK 3,483 the year before. Equity in the 2025 report amounted to DKK 28,083. The solvency ratio was 3.6%.
- Gross Profit
- DKK -1,395
- Profit/Loss
- DKK 4,372
- Equity
- DKK 28,083
- Total Assets
- DKK 773,020
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -1K | 4K | 28K | 0 |
| 2024 | - | -2K | 3K | 24K | - |
| 2023 | - | -1K | 9K | 20K | - |
| 2022 | 0 | -3K | 6K | 11K | - |
| 2021 | 0 | -47K | -11K | 5K | - |
Official annual report
How creditworthy is CanaDan Bio ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
CanaDan Bio ApS has published its annual report for 2024. Gross profit came to DKK -2,160, and the net result was DKK 3,483.
About CanaDan Bio ApS
CanaDan Bio ApS is a Danish company of the type Anpartsselskab based in Vanløse, founded in 2019. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Lionel le Lay. The company is owned by PYTHOR ApS and Megapol ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -1,395 and a net result of DKK 4,372 compared with DKK 3,483 the year before. Equity in the 2025 report amounted to DKK 28,083.